PRESS RELEASE published on 02/11/2025 at 20:28, 1 year 8 months ago Inside Information / Other news releases Poxel announces results of its Combined General Meeting with approved resolutions on revised remuneration policy for corporate officers. Details available on company's website Voting Results Financial Press Release Combined General Meeting Poxel Remuneration Policy
PRESS RELEASE published on 02/11/2025 at 20:28, 1 year 8 months ago Informations privilégiées / Autres communiqués Poxel annonce résultats Assemblée Générale Mixte du 11 février 2025, approbation résolutions et non-adoption délégations financières. Prochain communiqué financier : trésorerie et chiffre d'affaires Q4 2024 Résultats Trésorerie Assemblée Générale Mixte Poxel Approbation Résolutions
BRIEF published on 01/31/2025 at 07:35, 1 year 9 months ago POXEL annonce des ventes croissantes de TWYMEEG au Japon pour 2024 Revenus 2024 Poxel Sumitomo Pharma TWYMEEG Ventes Japon
BRIEF published on 01/31/2025 at 07:35, 1 year 9 months ago POXEL Announces Growing Sales of TWYMEEG in Japan for 2024 Poxel Sumitomo Pharma TWYMEEG Japan Sales 2024 Revenues
PRESS RELEASE published on 01/31/2025 at 07:30, 1 year 9 months ago Informations privilégiées / Autres communiqués Poxel annonce les ventes et prévisions de TWYMEEG® au Japon, avec une croissance de 17% au T4 2024 et des ventes prévues à 7,9 milliards de yens pour 2024 Japon Ventes Prévisions Poxel TWYMEEG
BRIEF published on 01/20/2025 at 07:35, 1 year 9 months ago POXEL atteint des ventes majeures avec TWYMEEG® au Japon TWYMEEG® Poxel Sumitomo Pharma Redevances Ventes Japon
BRIEF published on 01/20/2025 at 07:35, 1 year 9 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 9 months ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 9 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 10 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
Published on 10/30/2026 at 23:35, 17 hours 12 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 17 hours 17 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 21 hours 47 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 1 hour ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 11 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 17 hours 58 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 17 hours 47 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 17 hours 47 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
